SM
Sabby Management’s Iovance Biotherapeutics IOVA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q3 | – | Sell |
-71,251
| Closed | -$524K | – | 114 |
|
2017
Q2 | $524K | Buy |
71,251
+11,095
| +18% | +$81.6K | 0.03% | 61 |
|
2017
Q1 | $448K | Sell |
60,156
-165,925
| -73% | -$1.24M | 0.02% | 85 |
|
2016
Q4 | $1.57M | Sell |
226,081
-20,261
| -8% | -$141K | 0.09% | 36 |
|
2016
Q3 | $2.03M | Sell |
246,342
-120,900
| -33% | -$995K | 0.08% | 32 |
|
2016
Q2 | $2.98M | Sell |
367,242
-45,004
| -11% | -$365K | 0.16% | 24 |
|
2016
Q1 | $2.09M | Buy |
412,246
+142,246
| +53% | +$723K | 0.1% | 43 |
|
2015
Q4 | $2.08M | Sell |
270,000
-291,894
| -52% | -$2.25M | 0.11% | 40 |
|
2015
Q3 | $3.24M | Buy |
561,894
+134,650
| +32% | +$776K | 0.13% | 44 |
|
2015
Q2 | $3.92M | Buy |
427,244
+52,010
| +14% | +$477K | 0.14% | 29 |
|
2015
Q1 | $4.54M | Buy |
+375,234
| New | +$4.54M | 0.19% | 23 |
|